- Letter to Shareholders
- Interim consolidated financial statements 2024
- Interim consolidated statement of profit or loss
- Interim consolidated statement of profit or loss and other comprehensive income
- Interim consolidated balance sheet
- Interim Consolidated statement of cash flows
- Interim Consolidated statement of changes in equity
- Notes to the consolidated financial statements
- 1 Reporting entity
- 2 Basis of preparation and material accounting policies
- 3 Change in scope of consolidation: Acquisition through business combination
- 4 Revenue from contracts with customers and reconciliation to segment information
- 5 Segment information by business segments
- 6 Operating expenses by nature
- 7 Income taxes
- 8 Shareholders’ equity and employee participation plans
- 9 principal exchanges rates
- 10 Financial instruments and fair value disclosures
- 11 Subsequent events
- Global
5 SEGMENT INFORMATION BY BUSINESS SEGMENTS
| Life Sciences Business | Partnering Business | Corporate/ consolidation | Group
| ||||
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 |
January to June, CHF 1,000 |
|
|
|
|
|
|
|
|
Sales to third parties | 228,597 | 187,523 | 312,902 | 279,634 | - | - | 541,499 | 467,157 |
Intersegment sales | 5,313 | 3,312 | 674 | 476 | (5,987) | (3,788) | - | - |
|
|
|
|
|
|
|
|
|
Total sales | 233,910 | 190,835 | 313,576 | 280,110 | (5,987) | (3,788) | 541,499 | 467,157 |
|
|
|
|
|
|
|
|
|
Operating profit | 40,287 | 12,642 | 30,807 | 22,532 | (8,019) | (9,200) | 63,075 | 25,974 |
|
|
|
|
|
|
|
|
|
Depreciation and amortization | (11,223) | (14,507) | (21,851) | (19,404) | - | - | (33,074) | (33,911) |
| 2023 | 2024 |
January to June, CHF 1,000 |
|
|
Reconciliation of reportable segment sales |
|
|
Total sales for reportable segments | 547,486 | 470,945 |
Elimination of intersegment sales | (5,987) | (3,788) |
Total consolidated sales | 541,499 | 467,157 |
|
|
|
Reconciliation of reportable segment profit |
|
|
Total operating profit for reportable segments | 71,094 | 35,174 |
Unallocated costs (business development, investor relations and other corporate costs) and consolidation entries | (8,019) | (9,200) |
Financial result | (393) | 2,260 |
Total consolidated profit before taxes | 62,682 | 28,234 |
Follow Tecan